EMD-76963

Single-particle
3.2 Å
EMD-76963 Deposition: 29/04/2026
Map released: 08/07/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-76963

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-13cm summary report (pdf.gz) Map-13cm FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

HAdV-C5 Hexon with coagulation factor II

EMD-76963

Single-particle
3.2 Å
EMD-76963 Deposition: 29/04/2026
Map released: 08/07/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human adenovirus 5, Homo sapiens
Sample: Purified Human adenovirus type 5 hexon trimer in complex with prothrombin (FII)
Fitted models: 13cm

Deposition Authors: Ma OX, Reddy VS
Structural requirements of blood factors binding to soluble hexon trimers with implications for adenovirus cell targeting and immune evasion.
Ma OX, Lu SC, Mudrick HE, Barry ME, French JB, Barry MA, Reddy VS
(2026) PLoS Pathog , 22 , e1014389 - e1014389
PUBMED: 42441716
DOI: doi:10.1371/journal.ppat.1014389
ISSN: 1553-7374